[An open-label, multicentric clinical trial to evaluate the efficacy and impact on bone metabolism of recombinant human tumor necrosis factor-&#945; receptor II IgG Fc fusion protein with methotrexate in active rheumatoid arthritis: 24-week clinical and radiographic results from ReABLE study].

Wu, Qing-jun; Zhang, Zhuo-li; Li, Zhen-bin; Xu, Dong; Li, Guang-tao; Geng, Li-fen; Li, Meng-tao; Wang, Yu; Zhu, Jian-jun; Hao, Yan-jie; Hui, Nai-ling; Yang, Jing; Cui, Xiao-qing; Zhang, Xiao-gang; Zhao, Yan

[An open-label, multicentric clinical trial to evaluate the efficacy and impact on bone metabolism of recombinant human tumor necrosis factor-α receptor II IgG Fc fusion protein with methotrexate in active rheumatoid arthritis: 24-week clinical and radiographic results from ReABLE study].

Wu, Qing-jun; Zhang, Zhuo-li; Li, Zhen-bin; Xu, Dong; Li, Guang-tao; Geng, Li-fen; Li, Meng-tao; Wang, Yu; Zhu, Jian-jun; Hao, Yan-jie; Hui, Nai-ling; Yang, Jing; Cui, Xiao-qing; Zhang, Xiao-gang; Zhao, Yan.

Afiliação

Wu QJ; Department of Clinical Immunology & Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

Zhonghua Yi Xue Za Zhi ; 90(35): 2481-5, 2010 Sep 21.

Article em Zh | MEDLINE | ID: mdl-21092476

Assuntos

Antirreumáticos/uso terapêutico; Artrite Reumatoide/tratamento farmacológico; Metotrexato/uso terapêutico; Receptores Tipo II do Fator de Necrose Tumoral/uso terapêutico; Proteínas Recombinantes de Fusão/uso terapêutico; Adulto; Artrite Reumatoide/metabolismo; Quimioterapia Combinada; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Resultado do Tratamento

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Proteínas Recombinantes de Fusão / Metotrexato / Antirreumáticos / Receptores Tipo II do Fator de Necrose Tumoral Idioma: Zh Ano de publicação: 2010 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links